• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

    3.380 -0.050 (-1.46%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Iovance Biotherapeutics, Inc. - Common Stock

    < Previous 1 2
    ...
    16 17 18 19 20 21 22 23 Next >
    News headline image
    Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
    Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant... 
    Via PressReach
    News headline image
    Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
    Four-year Analysis of C-144-01 Trial Cohorts 2 and 4 
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Shares of Iovance Biotherapeutics Jumped Monday ↗
    The company's stock rally began on Friday. 
    Via The Motley Fool
    News headline image
    Where Iovance Biotherapeutics Stands With Analysts ↗
     
    Via Benzinga
    News headline image
    Expert Ratings for Iovance Biotherapeutics ↗
     
    Via Benzinga
    News headline image
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
    Gainers 
    Via Benzinga
    News headline image
    Over $26M Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying ↗
    Although U.S. stocks closed lower on Friday, there were a few notable insider trades. 
    Via Benzinga
    News headline image
    Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
    U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. Newegg Commerce, Inc. (NASDAQ: NEGG) shares climbed 8.7% to... 
    Via Benzinga
    News headline image
    Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today ↗
    The approval process for the biotech's most advanced pipeline drug program is going quite well, it seems. 
    Via The Motley Fool
    News headline image
    Personalized Skin Cancer Therapy, Despite FDA Delay: Analysts Show Confidence In Iovance Biotherapeutics Therapy ↗
    Thursday, the FDA extended the review period for Iovance Biotherapeutics Inc's (NASDAQ: IOVA) marketing application seeking accelerated approval for lifileucel  
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
    Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
    Via Benzinga
    News headline image
    Nasdaq Down Over 1%; US Industrial Output Rises In August ↗
    U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The... 
    Via Benzinga
    Topics Stocks
    Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is One of Friday Morning’s Most Active Stocks
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket ↗
    Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday. 
    Via Benzinga
    News headline image
    Mitek Systems, Arm Holdings And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗
    U.S. stock futures traded mostly higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session. 
    Via Benzinga
    News headline image
    U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced Melanoma
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Shares of Iovance Biotherapeutics Dropped Thursday ↗
    The biotech stock's lead therapy is looking at some competition. 
    Via The Motley Fool
    News headline image
    Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi. 
    Via Benzinga
    News headline image
    Iovance Biotherapeutics Stock Is Down 15%: What's Going On? ↗
    Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading lower by 15.8% to $4.58, despite a lack of company-specific news for the session. 
    Via Benzinga
    News headline image
    Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List ↗
    Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook. 
    Via InvestorPlace
    News headline image
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate Updates
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock ↗
     
    Via Benzinga
    News headline image
    Cathie Wood Buys $3.4M Worth Of Shares In This Payments Software Firm — Also Increases Exposure To Iridium Stock ↗
     
    Via Benzinga
    News headline image
    Cathie Wood's Ark Invest Sells Robinhood, Coinbase Shares — Buys $3.5M Worth Of Stock Of This Social Media Company ↗
     
    Via Benzinga
    < Previous 1 2
    ...
    16 17 18 19 20 21 22 23 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.